DJIA 17,122.01 15.31 0.09%
NASDAQ 4,569.62 -1.02 -0.02%
S&P 500 2,000.12 0.10 0.00%
market minute promo

169.17 -3.10 (-1.80%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ALXN $169.17 -1.80%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $172.33
Previous Close $172.27
Daily Range $168.76 - $172.72
52-Week Range $100.89 - $185.43
Market Cap $33.5B
P/E Ratio 86.57
Dividend (Yield) $0.00 (0.0%)
Volume 837,764
Average Daily Volume 1,160,458
Current FY EPS $4.58

Sector

Healthcare

Industry

Drugs

Alexion Pharmaceuticals, Inc. (ALXN) Description

A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions. Website: http://www.alexionpharm.com/

News & Commentary Rss Feed

Today's Top Health Care Stocks: Alexion Pharmaceuticals, Bristol-Myers Squibb, Celgene Corp. and Eli

Today's top stories in biotech and health care -- Alexion, Bristol-Myers Squibb, Celgene, and Eli Lilly

Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Bl

Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Blog

3 Drugs Stocks Dragging The Industry Down

Rising Short Interest in Biotech Stocks

5 Rocket Stocks to Buy for S&P 2,000

UPDATE: 8-K from Alexion Pharma Shows FDA Issued Form 483 at Aug. Inspection of Site, Does Not Expec

UPDATE: 8-K from Alexion Pharma Shows FDA Issued Form 483 at Aug. Inspection of Site, Does Not Expect Material Financial Effect Related to FDA Concern

Alexion Initiates Multinational Registration Trial of Eculizumab for Prevention of DGF after Kidney

Alexion Initiates Multinational Registration Trial of Eculizumab for Prevention of DGF after Kidney Transplantation

Jim Cramer's 'Mad Money' Recap: 12 Stocks Even Better Than Google

Biotech Stock Roundup: Achillion Scores in Mid-Stage Study, Gilead's Sovaldi Remains in Focus - Anal

Biotech Stock Roundup: Achillion Scores in Mid-Stage Study, Gilead's Sovaldi Remains in Focus - Analyst Blog

Amgen (AMGN) Reports Encouraging Top-Line Data on AMG 416 - Analyst Blog

5 Stocks Triggering Big Breakout Trades

See More ALXN News...

ALXN's Top Competitors

ALXN $169.17 (-1.80%)
Current stock: ALXN
AMGN $137.83 (0.41%)
Current stock: AMGN
GILD $107.41 (1.07%)
Current stock: GILD
BIIB $343.36 (0.11%)
Current stock: BIIB